Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication

Angiology

Volumn 57, Issue 2, 2006, Pages 145-154

  Silvestro, Antonio ^a,b   Schiano, Vittorio ^a   Bucur, Roxana ^a   Brevetti, Gregorio ^a   Scopacasa, Francesco ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Cardiology Division ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELL ADHESION MOLECULE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; PLACEBO; PROPIONYLCARNITINE; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; CARDIOTONIC AGENT; CARNITINE; DRUG DERIVATIVE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DILATATION; ARTICLE; BLOOD LEVEL; BOLUS INJECTION; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DETERIORATION; DIABETES MELLITUS; DRUG EFFICACY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; MALE; OBSERVER VARIATION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SMOKING; STATISTICAL ANALYSIS; TREADMILL EXERCISE; BLOOD; DRUG EFFECT; EXERCISE TEST; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; KINESIOTHERAPY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

BIOLOGICAL MARKERS; BRACHIAL ARTERY; CARDIOTONIC AGENTS; CARNITINE; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTERCELLULAR ADHESION MOLECULE-1; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION;

EID: 33645745518     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970605700203     Document Type: Article

References (47)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126, 1999.
2. Bogaty P, Hackett D, Davies G, et al: Vasoreactivity of the culprit lesion in unstable angina. Circulation 90:5-11, 1994.
3. Quyyumi AA: Endothelial function in health and disease: New insights into the genesis of cardiovascular disease. Am J Med 105:32S-39S, 1998.
4. Brevetti G, Silvestro A, Di Giacomo S, et al: Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 38:374-379, 2003.
5. Corretti MC, Anderson TJ, Benjamin EJ, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265, 2002.
6. Brevetti G, Martone VD, de Cristofaro T, et al: High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 85:63-66, 2001.
7. Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 170:191-203, 2003.
8. Silvestro A, Scopacasa F, Oliva G, et al: Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis 165:277-283, 2002.
9. Brevetti G, De Caterina M, Martone VD, et al: Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc 24:193-199, 2001.
10. Belch JJ, Mackay IR, Hill A, et al: Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int Angiol 14:385-388, 1995.
11. Brevetti G, Chiariello M, Ferulano G, et al: Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: A double-blind, cross-over study. Circulation 77:767-773, 1988.
12. Brevetti G, Perna S, Sabba C, et al: Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: An acute, intravenous, double-blind, cross-over study. Eur Heart J 13:251-255, 1992.
13. Brevetti G, Perna S, Sabba C, et al: Propionyl-L-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol 26:1411-1416, 1995.
14. Brevetti G, Diehm C, Lambert D: European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol 34:1618-1624, 1999.
15. Hiatt WR, Regensteiner JG, Creager MA, et al: Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 110:616-622, 2001.
16. Cerretelli P, Marconi C: L-carnitine supplementation in humans. The effects on physical performance. Int J Sports Med 11:1-14, 1990.
17. Reznick AZ, Kagan VE, Ramsey R, et al: Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: The possible role of iron chelation. Arch Biochem Biophys 296:394-401, 1992.
18. Packer L, Valenza M, Serbinova E, et al: Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys 288:533-537, 1991.
19. Stroh R, Christopher TA, Lopez BL, et al: L-propionyl carnitine, an endogenous ester in fatty acid metabolism, exerts anti-shock and endothelial protective effects in rat splanchnic ischemia-reperfusion injury. Shock 9:216-222, 1998.
20. Hickey NC, Shearman CP, Gosling P, et al: Assessment of intermittent claudication by quantitation of exercise-induced microalbuminuria. Eur J Vasc Surg 4:603-606, 1990.
21. Iwata H, Matsushita M, Nishikimi N, et al: Intestinal permeability is increased in patients with intermittent claudication. J Vasc Surg 31:1003-1007, 2000.
22. Kirk G, Hickman P, McLaren M, et al: Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease (PAOD). Eur J Vasc Endovasc Surg 18:434-438, 1999.
23. Edwards AT, Blann AD, Suarez-Mendez VJ, et al: Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg 81:1738-1741, 1994.
24. Verma S, Wang CH, Li SH, et al: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913-919, 2002.
25. Murohara T, Kugiyama K, Ohgushi M, et al: Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 266(3 Pt 2):H874-880, 1994.
26. Arsenian MA: Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis 40:265-286, 1997.
27. Triggiani M, Oriente A, Golino P, et al: Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. Biochem Pharmacol 58:1341-1348, 1999.
28. Garrelds IM, Elliott GR, Zijlstra FJ, et al: Effects of short- and long-term feeding of L-carnitine and congeners on the production of eicosanoids from rat peritoneal leucocytes. Br J Nutr 72:785-793, 1994.
29. O'Brien KD, McDonald TO, Chait A, et al: Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimai leukocyte content. Circulation 93:672-682, 1996.
30. Li H, Cybulsky MI, Gimbrone MA Jr, et al: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 13:197-204, 1993.
31. Brevetti G, Perna S, Sabba C, et al: Effect of propionyl-L-carnitine on quality of life in intermittent claudication. Am J Cardiol 79:777-780, 1997.
32. Brevetti G, di Lisa F, Perna S, et al: Carnitine-related alterations in patients with intermittent claudication: Indication for a focused carnitine therapy. Circulation 93:1685-1689, 1996.
33. Brevetti G, Angelini C, Rosa M, et al: Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation 84:1490-1495, 1991.
34. Brevetti G, Fanin M, De Amicis V, et al: Changes in skeletal muscle histology and metabolism in patients undergoing exercise deconditioning: Effect of propionyl-L-carnitine. Muscle Nerve 20:1115-1120, 1997.
35. Hulsmann WC, Dubelaar ML: Aspects of fatty acid metabolism in vascular endothelial cells. Biochimie 70:681-686, 1988.
36. Hulsmann WC, Dubelaar ML: Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemia. Mol Cell Biochem 116:125-129, 1992.
37. Bertelli A, Conte A, Ronca G, et al: Protective effect of propionyl carnitine against peroxidative damage to arterial endothelium membranes. Int J Tissue React 13:41-43, 1991.
38. Bertelli A, Conte A, Palmieri L, et al: Effect of propionyl carnitine on energy charge and adenine nucleotide content of cardiac endothelial cells during hypoxia. Int J Tissue React 13:37-40, 1991.
39. Sassen LM, Bezstarosti K, Van der Giessen WJ, et al: L-propionylcarnitine increases postischemic blood flow but does not affect recovery of energy charge. Am J Physiol 261(1 Pt 2):H172-H180, 1991.
40. Cipolla MJ, Nicoloff A, Rebello T, et al: Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism. J Vasc Surg 29:1097-1103, 1999.
41. Neunteufl T, Priglinger U, Heher S, et al: Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol 35:277-283, 2000.
42. Kanani PM, Sinkey CA, Browning RL, et al: Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100:1161-1168, 1999.
43. Title LM, Cummings PM, Giddens K, et al: Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: An effect prevented by vitamins C and E. J Am Coll Cardiol 36:2185-2191, 2000.
44. Spagnoli LG, Orlandi A, Marino B, et al: Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. Atherosclerosis 114:29-44, 1995.
45. Orlandi A, Marcellini M, Pesce D, et al: Propionyl-L-carnitine reduces intimai hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells. Atherosclerosis 160:81-89, 2002.
46. Brevetti G, Silvestro A, Schiano V, et al: Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108:2093-2098, 2003.
47. Gokce N, Keaney JF Jr, Hunter LM, et al: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41:1769-1775, 2003.